Literature DB >> 16837929

Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants.

D M Campbell1, P S Shah, V Shah, E N Kelly.   

Abstract

OBJECTIVE: To compare the feasibility of continuous positive airway pressure (CPAP) support generated by high flow nasal cannula with conventional CPAP for prevention of reintubation among preterm infants with a birth weight of <or=1,250 g. STUDY
DESIGN: Preterm infants were randomized to CPAP generated via high flow cannula or the Infant Flow Nasal CPAP System (VIASYS, Conshohocken, PA, USA) at extubation. Primary outcome was incidence of reintubation within 7 days. Secondary outcomes included change in oxygen use and frequency of apnea and bradycardias postextubation.
RESULTS: Forty neonates were randomized. Twelve of 20 infants randomized to high flow cannula CPAP were reintubated compared to three of 20 using Infant Flow (P=0.003). The high flow cannula group had increased oxygen use and more apneas and bradycardias postextubation.
CONCLUSIONS: CPAP delivered by high flow nasal cannula failed to maintain extubation status among preterm infants <or=1,250 g as effectively as Infant Flow CPAP.

Entities:  

Mesh:

Year:  2006        PMID: 16837929     DOI: 10.1038/sj.jp.7211561

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  18 in total

Review 1.  CPAP review.

Authors:  Olie Chowdhury; Catherine J Wedderburn; Donovan Duffy; Anne Greenough
Journal:  Eur J Pediatr       Date:  2011-12-16       Impact factor: 3.183

2.  Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP.

Authors:  Ruth-Maria Miksch; Sven Armbrust; Jens Pahnke; Christoph Fusch
Journal:  Eur J Pediatr       Date:  2008-01-03       Impact factor: 3.183

3.  High flow nasal cannula in extubated patients: is it advantageous over conventional oxygen therapy?

Authors:  Jian-Jun Zhang; Bing Dai
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 4.  High-flow nasal cannula therapy for respiratory support in children.

Authors:  Sara Mayfield; Jacqueline Jauncey-Cooke; Judith L Hough; Andreas Schibler; Kristen Gibbons; Fiona Bogossian
Journal:  Cochrane Database Syst Rev       Date:  2014-03-07

Review 5.  Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature.

Authors:  Jan Hau Lee; Kyle J Rehder; Lee Williford; Ira M Cheifetz; David A Turner
Journal:  Intensive Care Med       Date:  2012-11-10       Impact factor: 17.440

6.  Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery.

Authors:  A Schibler; T M T Pham; K R Dunster; K Foster; A Barlow; K Gibbons; J L Hough
Journal:  Intensive Care Med       Date:  2011-03-03       Impact factor: 17.440

7.  Work of breathing indices in infants with respiratory insufficiency receiving high-flow nasal cannula and nasal continuous positive airway pressure.

Authors:  B E de Jongh; R Locke; A Mackley; J Emberger; D Bostick; J Stefano; E Rodriguez; T H Shaffer
Journal:  J Perinatol       Date:  2013-09-26       Impact factor: 2.521

8.  Heated Humidified High-Flow Nasal Cannula for Prevention of Extubation Failure in Preterm Infants.

Authors:  Sasivimon Soonsawad; Buranee Swatesutipun; Anchalee Limrungsikul; Pracha Nuntnarumit
Journal:  Indian J Pediatr       Date:  2017-01-05       Impact factor: 1.967

9.  High Flow Nasal Cannula Use Is Associated with Increased Morbidity and Length of Hospitalization in Extremely Low Birth Weight Infants.

Authors:  Dalal K Taha; Michael Kornhauser; Jay S Greenspan; Kevin C Dysart; Zubair H Aghai
Journal:  J Pediatr       Date:  2016-03-19       Impact factor: 4.406

10.  Infant flow biphasic nasal continuous positive airway pressure (BP- NCPAP) vs. infant flow NCPAP for the facilitation of extubation in infants' ≤ 1,250 grams: a randomized controlled trial.

Authors:  Karel O'Brien; Craig Campbell; Leanne Brown; Lisa Wenger; Vibhuti Shah
Journal:  BMC Pediatr       Date:  2012-04-04       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.